Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
528 rows where has_cryoEM = 0, has_known_aptamer = 0 and surface_class = "A_surface" sorted by evidence_priority descending
This data as json, CSV (advanced)
surface_class 1
- A_surface · 528 ✖
has_known_aptamer 1
- - · 528 ✖
has_cryoEM 1
- - · 528 ✖
has_activation_state_pdb_pair 1
- 0 528
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P51795 | CLCN5 | H(+)/Cl(-) exchange transporter 5 | Tier 1.5 | 0.955 | 1 | A_surface | 2 | 80.62 | 0 | 0 | 0 | 0 | 1 | Dent disease type 1 | 0.850724240157394 | |||
| O00571 | DDX3X | ATP-dependent RNA helicase DDX3X | Tier 1 | 0.951 | 1 | A_surface | 17 | 72.19 | 0 | 0 | 0 | 0 | 1 | X-linked non-syndromic intellectual disability | 0.8362533125067105 | |||
| P25189 | MPZ | Myelin protein P0 | Tier 1.5 | 0.951 | 1 | A_surface | 2 | 81.69 | 0 | 0 | 0 | 0 | 1 | Charcot-Marie-Tooth disease type 1B | 0.8377022197539885 | |||
| P54760 | EPHB4 | Ephrin type-B receptor 4 | Tier 1 | 0.95 | 1 | A_surface | 23 | 82.0 | 0 | 0 | 0 | 0 | 1 | Capillary malformation - arteriovenous malformation | 0.8317426466005666 | |||
| Q8WZA1 | POMGNT1 | Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 | Tier 1 | 0.948 | 1 | A_surface | 10 | 89.88 | 0 | 0 | 0 | 0 | 1 | muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 | 0.826104223872448 | |||
| P13473 | LAMP2 | Lysosome-associated membrane glycoprotein 2 | Tier 1.5 | 0.948 | 1 | A_surface | 2 | 83.19 | 0 | 0 | 0 | 0 | 1 | Glycogen Storage Disease Type 2b | 0.8273010649608126 | |||
| O94766 | B3GAT3 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 | Tier 1 | 0.94 | 1 | A_surface | 3 | 92.56 | 0 | 0 | 0 | 0 | 1 | Larsen-like syndrome, B3GAT3 type | 0.7995331164339264 | |||
| Q14118 | DAG1 | Dystroglycan 1 | Tier 1 | 0.938 | 1 | A_surface | 8 | 68.19 | 0 | 0 | 0 | 0 | 1 | autosomal recessive limb-girdle muscular dystrophy type 2P | 0.7935290060634741 | |||
| Q9UPN3 | MACF1 | Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 | Tier 1 | 0.938 | 1 | A_surface | 3 | 0 | 0 | 0 | 0 | 1 | lissencephaly 9 with complex brainstem malformation | 0.7945569032416216 | ||||
| P08473 | MME | Neprilysin | Tier 1 | 0.937 | 1 | A_surface | 16 | 96.19 | 0 | 0 | 0 | 0 | 1 | Charcot-Marie-Tooth disease axonal type 2T | 0.7912653398252156 | |||
| P35916 | FLT4 | Vascular endothelial growth factor receptor 3 | Tier 1 | 0.937 | 1 | A_surface | 2 | 72.44 | 0 | 0 | 0 | 0 | 1 | lymphatic malformation 1 | 0.7904355931811005 | |||
| O75880 | SCO1 | Cytochrome c oxidase assembly factor SCO1 | Tier 1 | 0.935 | 1 | A_surface | 10 | 77.75 | 0 | 0 | 0 | 0 | 1 | mitochondrial complex IV deficiency, nuclear type 4 | 0.7827872588103603 | |||
| O94856 | NFASC | Neurofascin | Tier 1.5 | 0.933 | 1 | A_surface | 2 | 76.31 | 0 | 0 | 0 | 0 | 1 | neurodevelopmental disorder with central and peripheral motor dysfunction | 0.7782432580663833 | |||
| Q15746 | MYLK | Myosin light chain kinase, smooth muscle | Tier 1.5 | 0.93 | 1 | A_surface | 7 | 65.88 | 0 | 0 | 0 | 0 | 1 | aortic aneurysm, familial thoracic 7 | 0.7659842793171938 | |||
| O95714 | HERC2 | E3 ubiquitin-protein ligase HERC2 | Tier 1 | 0.925 | 1 | A_surface | 15 | 0 | 0 | 0 | 0 | 1 | developmental delay with autism spectrum disorder and gait instability | 0.74952129063985 | ||||
| Q02413 | DSG1 | Desmoglein-1 | Tier 1.5 | 0.92 | 1 | A_surface | 1 | 62.06 | 0 | 0 | 0 | 0 | 1 | severe dermatitis-multiple allergies-metabolic wasting syndrome | 0.7335328506238418 | |||
| Q9Y6N7 | ROBO1 | Roundabout homolog 1 | Tier 1 | 0.897 | 1 | A_surface | 12 | 60.0 | 0 | 0 | 0 | 0 | 1 | neurooculorenal syndrome | 0.6567040910170603 | |||
| Q13555 | CAMK2G | Calcium/calmodulin-dependent protein kinase type II subunit gamma | Tier 1.5 | 0.891 | 1 | A_surface | 2 | 78.38 | 0 | 0 | 0 | 0 | 1 | intellectual developmental disorder 59 | 0.6354497016986491 | |||
| P31431 | SDC4 | Syndecan-4 | Tier 1 | 0.885 | 1 | A_surface | 5 | 63.28 | 0 | 0 | 0 | 0 | 1 | non-small cell lung carcinoma | 0.6168120240815278 | |||
| Q92956 | TNFRSF14 | Tumor necrosis factor receptor superfamily member 14 | Tier 1.5 | 0.879 | 1 | A_surface | 8 | 79.94 | 0 | 0 | 0 | 0 | 1 | diffuse large B-cell lymphoma | 0.5983171413833771 | |||
| P20701 | ITGAL | Integrin alpha-L | Tier 1 | 0.877 | 1 | A_surface | 41 | 82.62 | 0 | 0 | 0 | 0 | 1 | psoriasis | 0.5899795223699872 | |||
| P0DOY3 | IGLC3 | Immunoglobulin lambda constant 3 | Tier 1 | 0.876 | 1 | A_surface | 4 | 96.06 | 0 | 0 | 0 | 0 | 1 | cutaneous Leishmaniasis | 0.5868213846274001 | |||
| P01859 | IGHG2 | Immunoglobulin heavy constant gamma 2 | Tier 1 | 0.876 | 1 | A_surface | 5 | 87.38 | 0 | 0 | 0 | 0 | 1 | cutaneous Leishmaniasis | 0.5868213846274001 | |||
| P01857 | IGHG1 | Immunoglobulin heavy constant gamma 1 | Tier 1 | 0.876 | 1 | A_surface | 100 | 86.69 | 0 | 0 | 0 | 0 | 1 | cutaneous Leishmaniasis | 0.5868213846274001 | |||
| P01597 | IGKV1-39 | Immunoglobulin kappa variable 1-39 | Tier 1.5 | 0.876 | 1 | A_surface | 2 | 90.5 | 0 | 0 | 0 | 0 | 1 | cutaneous Leishmaniasis | 0.5868213846274001 | |||
| P01764 | IGHV3-23 | Immunoglobulin heavy variable 3-23 | Tier 1.5 | 0.876 | 1 | A_surface | 6 | 91.0 | 0 | 0 | 0 | 0 | 1 | cutaneous Leishmaniasis | 0.5868213846274001 | |||
| P23083 | IGHV1-2 | Immunoglobulin heavy variable 1-2 | Tier 1.5 | 0.876 | 1 | A_surface | 1 | 91.75 | 0 | 0 | 0 | 0 | 1 | cutaneous Leishmaniasis | 0.5868213846274001 | |||
| P01593 | IGKV1D-33 | Immunoglobulin kappa variable 1D-33 | Tier 1.5 | 0.876 | 1 | A_surface | 6 | 90.88 | 0 | 0 | 0 | 0 | 1 | cutaneous Leishmaniasis | 0.5868213846274001 | |||
| P06312 | IGKV4-1 | Immunoglobulin kappa variable 4-1 | Tier 1.5 | 0.876 | 1 | A_surface | 10 | 90.62 | 0 | 0 | 0 | 0 | 1 | cutaneous Leishmaniasis | 0.5868213846274001 | |||
| Q10588 | BST1 | ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 | Tier 1 | 0.869 | 1 | A_surface | 6 | 89.62 | 0 | 0 | 0 | 0 | 1 | Parkinson disease | 0.5634966060310903 | |||
| Q16513 | PKN2 | Serine/threonine-protein kinase N2 | Tier 1 | 0.868 | 1 | A_surface | 4 | 71.44 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.5587297348479079 | |||
| P12318 | FCGR2A | Low affinity immunoglobulin gamma Fc region receptor II-a | Tier 1 | 0.866 | 1 | A_surface | 9 | 76.94 | 0 | 0 | 0 | 0 | 1 | ulcerative colitis | 0.5526669305497712 | |||
| Q96D96 | HVCN1 | Voltage-gated hydrogen channel 1 | Tier 1.5 | 0.865 | 1 | A_surface | 2 | 69.75 | 0 | 0 | 0 | 0 | 1 | Joubert syndrome | 0.5504227269701596 | |||
| Q12913 | PTPRJ | Receptor-type tyrosine-protein phosphatase eta | Tier 1 | 0.864 | 1 | A_surface | 5 | 77.75 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.54699134609967 | |||
| Q9P1W8 | SIRPG | Signal-regulatory protein gamma | Tier 1.5 | 0.864 | 1 | A_surface | 2 | 85.5 | 0 | 0 | 0 | 0 | 1 | type 1 diabetes mellitus | 0.5457344827318543 | |||
| O15155 | BET1 | BET1 homolog | Tier 1.5 | 0.864 | 1 | A_surface | 1 | 83.06 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.5468418315282804 | |||
| P04439 | HLA-A | HLA class I histocompatibility antigen, A alpha chain | Tier 1 | 0.863 | 1 | A_surface | 100 | 87.12 | 0 | 0 | 0 | 0 | 1 | diffuse large B-cell lymphoma | 0.5431777522591615 | |||
| P35052 | GPC1 | Glypican-1 | Tier 1 | 0.863 | 1 | A_surface | 4 | 82.5 | 0 | 0 | 0 | 0 | 1 | COVID-19 | 0.5430103345490354 | |||
| P29320 | EPHA3 | Ephrin type-A receptor 3 | Tier 1 | 0.863 | 1 | A_surface | 28 | 80.75 | 0 | 0 | 0 | 0 | 1 | medullary thyroid gland carcinoma | 0.5426301743186921 | |||
| P34741 | SDC2 | Syndecan-2 | Tier 1.5 | 0.863 | 1 | A_surface | 1 | 60.84 | 0 | 0 | 0 | 0 | 1 | COVID-19 | 0.5422254875204983 | |||
| Q15811 | ITSN1 | Intersectin-1 | Tier 1 | 0.859 | 1 | A_surface | 11 | 72.31 | 0 | 0 | 0 | 0 | 1 | genetic disorder | 0.5312614627352166 | |||
| O00161 | SNAP23 | Synaptosomal-associated protein 23 | Tier 1.5 | 0.859 | 1 | A_surface | 2 | 82.12 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.5288361677964304 | |||
| P54756 | EPHA5 | Ephrin type-A receptor 5 | Tier 1.5 | 0.858 | 1 | A_surface | 2 | 79.38 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.5261379875719714 | |||
| P54762 | EPHB1 | Ephrin type-B receptor 1 | Tier 1 | 0.856 | 1 | A_surface | 8 | 83.62 | 0 | 0 | 0 | 0 | 1 | medullary thyroid gland carcinoma | 0.5204553830376101 | |||
| Q9HCM2 | PLXNA4 | Plexin-A4 | Tier 1.5 | 0.856 | 1 | A_surface | 1 | 83.06 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.518371001420808 | |||
| P15814 | IGLL1 | Immunoglobulin lambda-like polypeptide 1 | Tier 1.5 | 0.85 | 1 | A_surface | 3 | 75.06 | 0 | 0 | 0 | 0 | 1 | isolated agammaglobulinemia | 0.4996673834185043 | |||
| P78552 | IL13RA1 | Interleukin-13 receptor subunit alpha-1 | Tier 1 | 0.846 | 1 | A_surface | 4 | 81.56 | 0 | 0 | 0 | 0 | 1 | type 2 diabetes mellitus | 0.48627783096767857 | |||
| P18084 | ITGB5 | Integrin beta-5 | Tier 1.5 | 0.846 | 1 | A_surface | 3 | 82.19 | 0 | 0 | 0 | 0 | 1 | migraine disorder | 0.48652455084344876 | |||
| P19440 | GGT1 | Glutathione hydrolase 1 proenzyme | Tier 1 | 0.845 | 1 | A_surface | 12 | 94.81 | 0 | 0 | 0 | 0 | 1 | alcoholic liver disease | 0.48228227774828414 | |||
| P01889 | HLA-B | HLA class I histocompatibility antigen, B alpha chain | Tier 1 | 0.845 | 1 | A_surface | 100 | 88.06 | 0 | 0 | 0 | 0 | 1 | COVID-19 | 0.48417012135481613 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;